Syndax Pharmaceuticals, Inc.

NMS: SNDX

Live Quote

📈 ZcoreAI Score

Our AI model analyzes Syndax Pharmaceuticals, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get SNDX Z-Score →

About Syndax Pharmaceuticals, Inc.

Healthcare Biotechnology

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.

📊 Fundamental Analysis

Syndax Pharmaceuticals, Inc. demonstrates a profit margin of -165.6%, which is below the sector average, suggesting competitive pressure.

The company recently reported 794.9% revenue growth, which is well above average for the Healthcare sector.

Return on Equity (ROE) is -161.8%, which indicates that capital utilization is currently under pressure.

At a current price of $24.44, SNDX currently trades near the top of its 52-week range (93%) (Range: $8.58 - $25.59).

🏥 Financial Health

🔴 Profit Margin Weak

🔴 Debt/Equity Elevated

✅ Revenue Growth Excellent

🔴 Return on Equity Weak

✅ Beta (Risk) Low Volatility

Key Financials

Market Cap

$2.16B

Trailing P/E

Forward P/E

-40.92

Beta (5Y)

0.41

52W High

$25.59

52W Low

$8.58

Avg Volume

1.38M

Day High

Day Low

Get SNDX Z-Score on Dashboard 🚀